Exacerbations and associated health-care cost in patients with chronic obstructive pulmonary disease (COPD) in general practice. Results from the COOPT trial Source: Eur Respir J 2002; 20: Suppl. 38, 398s Year: 2002
Spirometries in patients at a high risk of developing chronic obstructive pulmonary disease in general practices in Switzerland Source: Eur Respir J 2007; 30: Suppl. 51, 777s Year: 2007
Comorbidities in chronic obstructive pulmonary disease - Results of a national multicenter research project Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015
Perception of primary care physicians on chronic obstructive pulmonary disease and asthma: a study in India Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017
Prevalence of comorbid cardiovascular conditions in Russian patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 453s Year: 2006
Identifying patients with chronic obstructive pulmonary disease on an asthma register in primary care Source: Eur Respir J 2001; 18: Suppl. 33, 329s Year: 2001
Postural abnormalities in people with chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Postural balance, respiratory muscles, and comorbidities in chronic respiratory disease Year: 2016
How to screen chronic obstructive pulmonary disease in general practice? Source: International Congress 2015 – Respiratory disease management in primary care Year: 2015
Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers Year: 2006
Determinants of anxiety and depression among Filipino patients with chronic obstructive pulmonary disease: A multi-center study Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013
Recruitment for psychological therapy in chronic obstructive pulmonary disease (COPD) What factors influence participation? Source: Annual Congress 2013 –COPD treatment and others Year: 2013
Differentiating asthma from chronic obstructive pulmonary disease (COPD) in medico-economic databases: myth or reality? Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry Year: 2019
Epidemiology of COPD: social burden and trends for the future Source: Annual Congress 2006 - PG13 - COPD: from aetiology to management Year: 2006
COPD exacerbations in patients with chronic obstructive pulmonary disease in general practice in Ireland Source: Eur Respir J 2004; 24: Suppl. 48, 89s Year: 2004
Quantify comorbidities burden of chronic obstructive pulmonary disease patients using medication regimen complexity index Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016
Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits? Source: ERJ Open Res, 6 (2) 00099-2020; 10.1183/23120541.00099-2020 Year: 2020
Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 243-244 Year: 2002
Selection of patients with chronic obstructive pulmonary disease for participation in self-management programs. Source: Virtual Congress 2020 – Organising respiratory disease management in primary care Year: 2020
Does the severity of chronic obstructive pulmonary disease reflect on the outcomes of pulmonary rehabilitation? Source: Annual Congress 2007 - Assessment and outcomes in patients with chronic airway obstruction Year: 2007
Opioids and adverse outcomes in elderly chronic obstructive pulmonary disease patients Source: Eur Respir J 2016; 48: 1817 Year: 2016